Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical... see more

TSXV:THNK - Post Discussion

Think Research Corporation > Echelon Target $3.40.
View:
Post by KerBer on Apr 27, 2022 9:19pm

Echelon Target $3.40.

https://www.cantechletter.com/2022/04/133353/
Comment by Possibleidiot01 on Apr 28, 2022 6:05am
  Think Research is undervalued, Echelon says (April, 2022) By Jayson MacLean Published on April 27, 2022 Last Updated on April 27, 2022 Filed under:   All posts, Analysts, Health Stock:   thnk Echelon Capital Markets analyst Rob Goff sees a big market disconnect on Think Research Corp. (Think Research Stock ...more  
Comment by dt_core on May 07, 2022 4:06pm
It looks like most 12 month target prices for the company range from $2.00 to $2.90 now. That's down a bit as analysts adjusted their models for higher discount rates now being reflected more generally in the markets. Very few analysts adjusted their fundamental targets for the company. As an aside, with the stock now trading where it is we're seeing some implications of the poor capital ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities